Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Head and Neck Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma 2Prostatic Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms 2Melanoma 2Lymphedema 2Hematologic Neoplasms 2Carcinoma, Squamous Cell 2Breast Neoplasms 2Tongue Neoplasms 1Testicular Neoplasms 1Teratoma 1Smoking Cessation 1Smoking 1Sexual Dysfunction, Physiological 1Polyps 1Peritoneal Neoplasms 1Paraganglioma, Extra-Adrenal 1Pain 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Oligodendroglioma 1Neuroblastoma 1Neoplasms, Plasma Cell 1Mouth Neoplasms 1Medulloblastoma 1

Interventions

Cyclophosphamide 32Tacrolimus 29fludarabine 27Mycophenolic Acid 23fludarabine phosphate 22Busulfan 19Whole-Body Irradiation 18Melphalan 16Methotrexate 15Antilymphocyte Serum 14Rituximab 12Bortezomib 11Stem Cell Transplantation 10Cyclosporine 10thymoglobulin 9Sirolimus 9Granulocyte Colony-Stimulating Factor 9Peripheral Blood Stem Cell Transplantation 8Thiotepa 7Interviews as Topic 7Filgrastim 7Dexamethasone 7Clofarabine 7Blood Specimen Collection 6Alemtuzumab 6merphos 5Voriconazole 5Standard of Care 5Nivolumab 5Lenalidomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Hematologic Neoplasms × Restraint, Physical × Clear all
NCT02359838 2022-07-19

Patient-Centered Care for the Older Adult With Hematologic Malignancy

Dana-Farber Cancer Institute

Phase NA Completed
160 enrolled 7 charts
Other hematologic neoplasm

Frailty, Hematologic Neoplasms

NCT02824159 2020-12-28

PK-E3I

University Hospital, Toulouse

Completed
121 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡